Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03359239
Title Atezolizumab Given in Combination With a Personalized Vaccine in Patients With Urothelial Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Matthew Galsky
Indications

urethra transitional cell carcinoma

ureter transitional cell carcinoma

bladder urothelial carcinoma

renal pelvis transitional cell carcinoma

Therapies

Atezolizumab + PGV 001

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.